The Use of Methylnaltrexone to Reduce Post-operative Opioid-induced Constipation in the Pediatric Spinal Fusion Patient
Phase of Trial: Phase IV
Latest Information Update: 20 May 2013
At a glance
- Drugs Methylnaltrexone bromide (Primary) ; Bisacodyl; Docusate sodium; Magnesium hydroxide; Senna-alexandrina
- Indications Constipation
- Focus Therapeutic Use
- 20 May 2013 Planned end date changed from 1 Apr 2015 to 1 Jun 2015 as reported by ClinicalTrials.gov.
- 01 May 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 28 Feb 2013 Planned number of patients changed from 100 to 60 as reported by ClinicalTrials.gov.